Moderna to replace Warner Bros Discovery on Nasdaq 100

Nasdaq announced Moderna will replace Warner Bros. Discovery on the Nasdaq 100 index, effective October 9. Moderna's shares have risen over sixfold this year, valuing the company at about $75 billion. Warner Bros. Discovery is also set to be removed from other major indexes due to its upcoming merger with Paramount Skydance.

Original reporting
Published Oct 2, 2026, 12:34 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 2, 2026, 12:51 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$MRNA
Bullish
high confidence
Mentioned
$MRNA · $WBD
Relevance
7/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$MRNABullishMed
01

Why it matters

The addition of a high‑growth biotech could attract inflows, while the removal of a media company may trigger outflows, influencing both stocks and related ETFs.

02

Market read

Index composition changes affect passive fund flows and can cause short‑term price moves in the affected securities.

03

What to watch

Potential short‑term volatility from algorithmic rebalancing and tax‑loss harvesting around the effective date.

Relevance 7/10Novelty 7/10Timing: effective October 9

Background

Nasdaq announced a routine index reconstitution, adding Moderna and removing Warner Bros. Discovery as part of its quarterly update.

Company-level read

Ticker impact

$MRNABullishHigh confidence
Context

Moderna will be added to the Nasdaq‑100 index effective October 9, replacing Warner Bros. Discovery.

Expected impact

likely upward pressure as passive funds add shares

Evidence & confidence

Index additions typically generate buying from ETFs and institutional investors.

$WBDBearishHigh confidence
Context

Warner Bros. Discovery will be removed from the Nasdaq‑100 index effective October 9 after its merger with Paramount Skydance.

Expected impact

likely downward pressure as funds sell to rebalance

Evidence & confidence

Index deletions often trigger selling by ETFs and passive managers.

Market effects

The change slightly alters the biotech weighting in the Nasdaq‑100, marginally affecting sector exposure.

U.S. equity indices will adjust composition, with minor ripple effects on global index funds.

Limited to investors tracking the Nasdaq‑100; no broader macro impact.

Counterpoint

If the market has already priced the index change, the actual price move may be muted.

Key entities

  • Moderna

    Biotech firm developing mRNA vaccines, now joining the Nasdaq‑100.

  • Warner Bros. Discovery

    Media conglomerate being removed from the Nasdaq‑100 after its merger.

Related articles

$WBDHighAI 9/10

Paramount Skydance Nears Acquisition of Warner Bros. Discovery (

Paramount Skydance is nearing the acquisition of Warner Bros. Discovery (WBD), pending closing conditions. WBD's P/S ratio is 2.14, above its historical median and industry average, indicating high growth expectations despite unprofitability. The company's GF Score is 57, reflecting moderate financial health. Insiders have sold $406.3 million in shares over the past year, while gurus have mixed activity. Post-merger, Paramount Skydance plans to list on the NYSE.